FONAR Corporation (FONR)
NASDAQ: FONR
· Real-Time Price · USD
15.70
-0.08 (-0.53%)
At close: Sep 11, 2025, 3:59 PM
15.70
0.00%
After-hours: Sep 11, 2025, 04:00 PM EDT
FONAR Revenue Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Health Care, Other Revenue | 24.77M | 23.12M |
| Health Care, Other Revenue Growth | +7.13% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.99M | 6.93M | 5.13M | 8.82M | 7.59M | 5.59M | 4.87M | 9.32M | 7.14M | 6.6M | 6.33M | 7.58M | 6.07M | 4.77M | 5.09M | 7.92M | 6.11M | 4.54M | 6.16M | 11.03M | 7.22M | 4.16M | 4.29M | 6.79M | 4.6M | 3.61M | 4.26M | 5.23M | 5.53M | 3.29M | 4.08M | 6.79M | 4.48M | 4.07M | 4.07M | 6.08M | 4.53M | 4.12M | 3.77M | 2.35M | 3.71M |
| Selling, General, and Administrative Revenue Growth | +15.36% | +35.03% | -41.85% | +16.20% | +35.90% | +14.82% | -47.77% | +30.43% | +8.26% | +4.17% | -16.49% | +24.99% | +27.21% | -6.29% | -35.75% | +29.57% | +34.64% | -26.32% | -44.11% | +52.63% | +73.53% | -3.05% | -36.74% | +47.43% | +27.53% | -15.24% | -18.51% | -5.54% | +68.38% | -19.48% | -39.90% | +51.47% | +10.17% | +0.10% | -33.19% | +34.23% | +10.10% | +9.06% | +60.54% | -36.55% | n/a |
| Research and Development Revenue | 441K | 376K | 307K | 438.95K | 414K | 416K | 467K | 441.75K | 435K | 342K | 349K | 385.18K | 354K | 370K | 386K | 392.98K | 419K | 424K | 400K | 435.38K | 535K | 583K | 472K | 444.35K | 381K | 550K | 437K | 497.75K | 503K | 407K | 349K | 375.67K | 332K | 361K | 412K | 388.85K | 395K | 412K | 436K | 696.4K | 360K |
| Research and Development Revenue Growth | +17.29% | +22.48% | -30.06% | +6.03% | -0.48% | -10.92% | +5.72% | +1.55% | +27.19% | -2.01% | -9.39% | +8.81% | -4.32% | -4.15% | -1.78% | -6.21% | -1.18% | +6.00% | -8.13% | -18.62% | -8.23% | +23.52% | +6.22% | +16.63% | -30.73% | +25.86% | -12.20% | -1.04% | +23.59% | +16.62% | -7.10% | +13.15% | -8.03% | -12.38% | +5.95% | -1.56% | -4.13% | -5.50% | -37.39% | +93.44% | n/a |